The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. We are absolutely ecstatic,” George Hodgin, the CEO of the Castroville, California based Biopharmaceutical Research Co. Junk’ cannabis ‘ill-suited for clinical trials’.

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

Cannabis Law Report

JUNE 19, 2022

The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives.

Education 52

Education Research and Development Therapy Clinical Trials 52

MMJ Recs

MAY 9, 2024

Exploring Different Consumption Methods: Medical marijuana comes in various forms, including flowers, concentrates, edibles, tinctures, and topicals. Veterans’ Access to Medical Marijuana The benefits of medical cannabis for veterans are many, but access to medical marijuana for veterans has been a topic of ongoing debate and advocacy.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 218

CBD Blood Pressure Research and Development Cannabinoids 218

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. RYAH’s database provides that type of scale to all parties involved – patients, doctors, researchers, drug developers, growers, etc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JUNE 15, 2022

Materia is one of many other operators that have recently established a headquarters in Malta since the legislation permitting the production of medical cannabis products for research and medical purposes was enacted in 2018. Malta is an ideal testbed for research given its small size and business-friendly approach.

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Packaging 52

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. But would tolerance develop with repeated dosing, thereby mitigating CBD ’s hypotensive effect?

CBD 177

CBD Blood Pressure Research and Development Cannabinoids 177

Cannabis Law Report

AUGUST 17, 2021

This growth opportunity-technology report explores innovations and patents in this space and provides more details about notable companies that are making strides in research and development. Key Topics Covered: 1.0 Research Context and Key Findings. Research Scope. Research Methodology. Research Scope.

Research and Development 98

Research and Development Clinical Trials Concentrates Patients 98

Cannabis Law Report

JANUARY 10, 2022

In addition, rising strategic initiatives by key players in the form of collaborations, clinical trials, and production are further contributing to increasing awareness and adoption of THCV products. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Cannabinoids 52

Cannabinoids Clinical Trials Research and Development Supply Chain 52

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. As few as 10% of ALS patients live longer than 10 years after being diagnosed.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Cannabis Law Report

JANUARY 19, 2022

During his 24 years in Congress, Congressman Moran was recognized as a champion of innovative research and development in areas including healthcare and national security, environmental protection and sustainability, and international trade and fiscal responsibility. About IGC: India Globalization Capital, Inc.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

PrestoDoctor

OCTOBER 11, 2023

For years, the use of cannabis has been a controversial topic. One area of research that has been gaining attention is the use of CBD-rich cannabis in treating the social symptoms of Autism Spectrum Disorder (ASD). Some individuals may have delayed speech development or struggle with expressing their thoughts and emotions effectively.

CBD 52

CBD Research and Development Clinical Trials Treatment 52

Cannabis Law Report

MARCH 16, 2022

PsyBio Therapeutics to Make Significant Environmental, Social, and Governance (ESG) Commitment to Promote Mental and Neurological Health While Working to Develop State of the Art Technologies, Process Skills and Capabilities in Lesotho and Across Africa. OXFORD, Ohio and COCONUT CREEK, Fla., per SVS.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Medicine 52

Cannabis Law Report

AUGUST 16, 2021

–(BUSINESS WIRE)–Celebrity blogger and media personality Perez Hilton and leading hemp-based CBD researchers have forged a business partnership in support of My True 10 , a CBD Gummies line available at mytrue10.com Perez Hilton’s Personal Wellness Journey Encourages & Supports Others to Live Well. CARSON CITY, Nev.–(BUSINESS

Food 105

Food CBD Research and Development Clinical Trials 105

MMJ Recs

DECEMBER 28, 2023

In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

SEPTEMBER 6, 2021

The steadily aging population across the globe has played a significant role in driving the demand for medical cannabis as geriatric patients are more likely to develop chronic illnesses and require more physician visits. Key Topics Covered: 1 Preface. Key Topics Covered: 1 Preface. 2 Scope and Methodology. 3 Executive Summary.

Chronic Pain 86

Chronic Pain Research and Development Clinical Trials Epilepsy 86

The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

The Cannigma

SEPTEMBER 21, 2021

Patrick Stewart uses topicals and edibles for his arthritis (Shutterstock). Chong told Forbes that after he was cast on Dancing With The Stars, the stress and strain of the dancing built up and led him, in his estimation, to develop rectal cancer as well. 1) Patrick Stewart. 7) Morgan Freeman. 8) Michael J. The Michael J.

Patients 94

Patients Research and Development Sleep Clinical Trials 94

United Patients Group

JANUARY 5, 2023

Probiotics are a hot topic these days, and for good reason. A growing body of research suggests that probiotics can help protect us from illness and disease, improve our mental health, and strengthen our immune system. Probiotics may reduce the risk of developing a cold or flu. Introduction. Probiotics May Reduce Flu Risk.

Digestion 87

Digestion Research and Development Food Strains 87

Greencamp

FEBRUARY 17, 2019

The science and research behind cannabis and IBS has linked the imbalances of our endocannabinoid system with certain IBS symptoms. Crohn’s Disease and Marijuana: Efficacy, Research and Dosing. In fact, the risk of developing IBS increases after a gastrointestinal infection for about 10%. Research on cannabis and IBS.

Digestion 96

Digestion Research and Development Marijuana Cannabinoids 96

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Marijuana law reform advocates and many medical researchers have been fighting to change marijuana’s Schedule I classification for years. Schedule I classification typically pertains to narcotic substances with no medical value.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

MMJ Recs

DECEMBER 22, 2023

Medical marijuana, once a controversial and stigmatized topic, has undergone a remarkable transformation in the eyes of the American public. Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

Cannabis Law Report

JUNE 25, 2021

This acquisition would also help Bristol-Myers Squibb to expedite the development of new innovative drugs which are in the early stages of drug pipeline. Celgene is an innovative biotechnology company that manufactures and develops cancer drugs. Key Topics Covered: 1. Cancer Research Centers. Executive Summary.

Research and Development 84

Research and Development Therapy Pharmaceutical Clinical Trials 84

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease. Cost of revenue. . .

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

The Cannigma

JUNE 24, 2021

Research has found that meditation can potentially have a variety of health benefits , including lowering blood pressure, reducing anxiety and depression, and may even provide some relief from conditions like irritable bowel syndrome and ulcerative colitis. Meditation and mindfulness. How CBD and cannabis products can help.

CBD 75

CBD Microdosing Edibles Sleep 75

Cannabis Law Report

FEBRUARY 3, 2022

Based on route of administration, the market is segmented into oral, topical, inhalation, rectal, sublingual. Product Development Via Research and Novel Product Delivery Solutions. Researchers Are Studying New Uses of Medical Marijuana. Clinical Trials of Cannabis Are Still on Going. Opportunities.

Indica 52

Indica Oil Legalization Research and Development 52

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JANUARY 11, 2019

Food and Drug Administration (FDA) retains its authority to regulate ingestible and topical products, including those that contain hemp and hemp extracts such as CBD. There is no signal for the development of substance use disorder in individuals consuming CBD-containing products.”. “It

Hemp 49

Hemp CBD Law Seed-To-Sale 49

TheAnswerPage

JANUARY 11, 2022

Thus, an educational gap developed, creating a less than ideal situation for medical marijuana patients. So, why did this educational gap develop? Unfortunately, this did not occur. Medical marijuana, unlike every other legal medication in the US, has been legalized by the vote of the public and the work of policymakers.

Patients 98

Patients Education Marijuana Therapy 98

MGC Pharma

FEBRUARY 20, 2018

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

Research and Development 100

Research and Development Clinical Trials Patients Chronic Pain 100

The Blunt Truth

AUGUST 13, 2019

The following is a brief update on recent developments within the federal regulatory regime of CBD products. . 331(ll)), the FDA prohibits the sale of products containing an ingredient that has been treated as a drug or involved in clinical trials, without prior FDA approval. FDA’s Regulatory Efforts. First, Sens.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

NOVEMBER 15, 2021

Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We This product candidate is being funded through a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS).

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

Cannabis Law Report

NOVEMBER 10, 2021

– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS IND-enabling studies for Envelta are being performed under a Cooperative Research and Development Agreement (CRADA) with NCATS entered into by Virpax in August of 2020. “We

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

OCTOBER 6, 2021

Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”).

Research and Development 52

Research and Development Clinical Trials Pharmaceutical Chronic Pain 52

Cannabis Law Report

SEPTEMBER 10, 2019

They write, “ At the Center for Psychedelic and Consciousness Research, researchers will focus on how psychedelics affect behavior, mood, cognition, brain function, and biological markers of health. The researchers hope to create precision medicine treatments tailored to the specific needs of individual patients.

Research and Development 45

Research and Development Microdosing Clinical Trials Decriminalization 45

Cannabis Law Report

SEPTEMBER 28, 2021

DUBLIN–(BUSINESS WIRE)–The “Epilepsy – Pipeline Insight, 2021” clinical trials has been added to ResearchAndMarkets.com’s offering. It covers the pipeline drug profiles, including clinical and nonclinical stage products. GWP42003-P: GW Research. Epilepsy Emerging Drugs Chapters.

Epilepsy 52

Epilepsy Clinical Trials Research and Development Pharmaceutical 52